May 13, 2011 by Karl ThielPacific Biosciences Has a PR ProblemPacBio is hard to break down to a sound bite, but that could spell opportunity for long-term investors.
Aug 27, 2010 by Karl ThielWarren Buffett's Trades: Visualizing the Oracle's Portfolio TweaksA look at Berkshire Hathaway's recent moves.
Sep 22, 2009 by Karl ThielHow I'm Saving Way More Than the ChineseThere's one easy way to take a big bite out of your expenses.
Oct 30, 2008 by Karl ThielMagnify Your Profits From the Bounce Growth investing in tough times can be tough, but don't give up.
Oct 21, 2008 by Karl ThielGreat Stocks for a Vertical WorldFlat may be trendy, but there a lot of advantages to being vertical.
Oct 9, 2007 by Karl ThielFoolish Interview: Momenta's Craig WheelerThe drug company is banking on a generic for blood clots and heart problems.
Jun 6, 2007 by Karl ThielWhat Is That Stock Price Telling You?In biotech investing, it pays to close your ears to all the hubbub.
Jan 19, 2007 by Karl ThielThe Best Drug Stock for 2007: MomentaSwing for the fences with this drug company.
Nov 20, 2006 by Karl ThielTrimeris Begs for a BuyoutThe pharmaceutical's reorganization plan practically posts a "for sale" sign.
Nov 9, 2006 by Karl ThielThe Best Blue Chip for 2007: AmgenOnce a small biotech struggling to make its way in the world, Amgen has grown up.
Sep 29, 2006 by Karl ThielIs an HSA Right for You?Health savings accounts can help you reduce costs -- if you know how they work.
Jul 20, 2006 by Karl ThielA Blueprint to Biotech ProfitsThree keys to identifying promising biotech companies before the rest of the market.
Mar 28, 2006 by Karl ThielFrom Homeless to Home FreeOne woman's journey should be a lesson to us all.
Feb 27, 2006 by Karl ThielIs an HSA Right for You?The relatively new health savings accounts make going it alone a whole lot easier than it was a few years ago.
Feb 17, 2006 by Karl ThielStock DopingChannel stuffing in the pharmaceutical industry and elsewhere can mask the condition of a company's financials and cost investors gold.
